Your browser doesn't support javascript.
loading
SEOM Clinical Guideline in ovarian cancer (2016)
Santaballa, A; Barretina, P; Casado, A; García, Y; González-Martín, A; Guerra, E; Laínez, N; Martinez, J; Redondo, A; Romero, I.
Affiliation
  • Santaballa, A; Hospital Universitari I Politècnic La Fe. Servicio de Oncología Médica. Valencia. Spain
  • Barretina, P; Institut Català d’Oncologia. Servicio de Oncología Médica. Girona. Spain
  • Casado, A; Hospital Clínico Universitario, San Carlos. Servicio de Oncología Médica. Madrid. Spain
  • García, Y; Corporació Sanitària Parc Taulí. Servicio de Oncología Médica. Sabadell. Spain
  • González-Martín, A; MD Anderson Cancer Center. Servicio de Oncología Médica. Madrid. Spain
  • Guerra, E; Hospital Universitario Ramón y Cajal. Servicio de Oncología Médica. Madrid. Spain
  • Laínez, N; Complejo Hospitalario de Navarra. Servicio de Oncología Médica. Pamplona. Spain
  • Martinez, J; Hospital Universitario Virgen de la Arrixaca. Servicio de Oncología Médica. Murcia. Spain
  • Redondo, A; Hospital Universitario La Paz. Servicio de Oncología Médica. Madrid. Spain
  • Romero, I; Fundación Instituto Valenciano de Oncología. Servicio de Oncología Médica. Valencia. Spain
Clin. transl. oncol. (Print) ; 18(12): 1206-1212, dic. 2016. tab
Article in English | IBECS | ID: ibc-158636
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer (OC) is the first cause of death due to gynecological cancer and the fifth cause of death for cancer in women in Spain. The aim of this guideline is to summarize the current evidence and to give evidence-based recommendations for clinical practice (AU)
RESUMEN
No disponible
Subject(s)
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: National databases / Spain Health context: SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Endocrine System Diseases / Ovary Cancer Database: IBECS Main subject: Ovarian Neoplasms / Bevacizumab / Neoplasm Recurrence, Local Type of study: Practice guideline Limits: Female / Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2016 Document type: Article Institution/Affiliation country: Complejo Hospitalario de Navarra/Spain / Corporació Sanitària Parc Taulí/Spain / Fundación Instituto Valenciano de Oncología/Spain / Hospital Clínico Universitario, San Carlos/Spain / Hospital Universitari I Politècnic La Fe/Spain / Hospital Universitario La Paz/Spain / Hospital Universitario Ramón y Cajal/Spain / Hospital Universitario Virgen de la Arrixaca/Spain / Institut Català d’Oncologia/Spain / MD Anderson Cancer Center/Spain
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: National databases / Spain Health context: SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Endocrine System Diseases / Ovary Cancer Database: IBECS Main subject: Ovarian Neoplasms / Bevacizumab / Neoplasm Recurrence, Local Type of study: Practice guideline Limits: Female / Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2016 Document type: Article Institution/Affiliation country: Complejo Hospitalario de Navarra/Spain / Corporació Sanitària Parc Taulí/Spain / Fundación Instituto Valenciano de Oncología/Spain / Hospital Clínico Universitario, San Carlos/Spain / Hospital Universitari I Politècnic La Fe/Spain / Hospital Universitario La Paz/Spain / Hospital Universitario Ramón y Cajal/Spain / Hospital Universitario Virgen de la Arrixaca/Spain / Institut Català d’Oncologia/Spain / MD Anderson Cancer Center/Spain